Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT Study) --a rebuttal
Hirschfield, G.
Thrombosis and Haemostasis 85(1): 189-190
2001
ISSN/ISBN: 0340-6245 PMID: 11204580 Document Number: 534465
Document emailed within 1 workday
Related Documents
Glas-Greenwalt, P.; Hall, J.M.; Panke, T.W.; Kant, K.S.; Allen, C.M.; Pollak, V.E. 1986: Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura Journal of Laboratory and Clinical Medicine 108(5): 415-422Boutsikas, G.; Terpos, E.; Markopoulos, A.; Papatheodorou, A.; Stefanou, A.; Georgiou, G.; Galani, Z.; Komninaka, V.; Telonis, V.; Anagnostopoulos, I.; Dimitrakopoulou, L.; Anargyrou, K.; Tsionos, K.; Christoulas, D.; Gonianaki, M.; Giannikos, T.; Kokoris, S.; Konstantopoulos, K.; Meletis, J.; Angelopoulou, M.K.; Travlou, A.; Vassilakopoulos, T.P. 2017: Protein Z (PZ) and plasminogen activator inhibitor-1 (PAI-1) plasma levels in patients with previously untreated Hodgkin lymphoma (HL) Journal of BUON: Official Journal of the Balkan Union of Oncology 22(4): 1022-1031
Jastrzebska, M.; Przybycień, K.; Chelstowski, K.; Torbus-Lisiecka, B.; Kornacewicz-Jach, Z.; Naruszewicz, M. 1999: Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial triglyceridemia in patients with ischemic heart disease confirmed by angiography Nutrition Metabolism and Cardiovascular Diseases: Nmcd 9(1): 33-40
Sattar, N.; McMillan, D.C. 1998: Association between plasma plasminogen activator inhibitor-1 and survival in colorectal cancer. Measuring C reactive protein concentrations may be more useful Bmj 317(7160): 750-751
Ndrepepa, G.; Braun, S.; Tada, T.; King, L.; Cassese, S.; Fusaro, M.; Keta, D.; Kastrati, A.; Schmidt, R. 2014: Comparative prognostic value of C-reactive protein and fibrinogen in patients with coronary artery disease Indian Journal of Medical Research 140(3): 392-400
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Chen, Z.Y. 1993: A study on the circadian variation of tissue-type plasminogen activator and its rapid inhibitor in patients with coronary heart disease Zhonghua Xin Xue Guan Bing Za Zhi 21(3): 163-164; 188
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Andreotti, F.; Hackett, D.R.; Haider, A.W.; Roncaglioni, M.C.; Davies, G.J.; Beacham, J.L.; Kluft, C.; Maseri, A. 1992: Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction Thrombosis and Haemostasis 68(6): 678-682
Virji, M.A.; Aggarwal, S.; Kang, Y. 1989: Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation Transplantation Proceedings 21(3): 3540-3541
Bolan, C.D.; Krishnamurti, C.; Tang, D.B.; Carrington, L.R.; Alving, B.M. 1993: Association of protein S deficiency with thrombosis in a kindred with increased levels of plasminogen activator inhibitor-1 Annals of Internal Medicine 119(8): 779-785
Folsom, A.R.; Pankow, J.S.; Williams, R.R.; Evans, G.W.; Province, M.A.; Eckfeldt, J.H. 1998: Fibrinogen, plasminogen activator inhibitor-1, and carotid intima-media wall thickness in the NHLBI Family Heart Study Thrombosis and Haemostasis 79(2): 400-404
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583
Młynarska, A.; Waszyrowski, T.; Kasprzak, J.ła.D. 2007: Plasminogen activator inhibitor-1 (PAI-1): pathogenetic role in coronary disease Kardiologia Polska 65(9): 1109-1114
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
Seyyed Mohammad Reza Kazemi-Bajestani; Ghayour, M.-Mobarhan; Ebrahimi, M.; Moohebati, M.; Habib-Esmaeili, A.; Gordon A. A. Ferns 2007: C-reactive Protein Associated with Coronary Artery Disease in Iranian Patients with Angiographically Defined Coronary Artery Disease Clinical Laboratory 53(1-2): 49-56
Kruithof, E.K.; Gudinchet, A.; Bachmann, F. 1988: Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states Thrombosis and Haemostasis 59(1): 7-12
Yang, L.; Tian, X.; Guo, R.; Liu, H.; Qi, F.; Ye, J. 2014: Relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer and urokinase-type plasminogen activator in patients with coronary artery disease Zhonghua Xin Xue Guan Bing Za Zhi 42(9): 740-743